Science Explorer Back to mapMap
Discussion
Company · Bethlehem · United States

Azevan Pharmaceuticals (United States)

azevan.comROR OpenAlex
Research works
7
▼ 28% vs 2018-21
Citations
212
30.3 per fractional work
Top-10% rate
41.5%
all institutions 10.0%
Open access
50%
world 40%
International
5%
world 18%
Azevan Pharmaceuticals (United States)

Not ranked overall: Azevan Pharmaceuticals (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Azevan Pharmaceuticals (United States) work in?

In all years, 37% of research at Azevan Pharmaceuticals (United States) is in Life Sciences, 36% in Health Sciences. Its largest fields are Medicine (32%), Neuroscience (28%), Psychology (26%). It does 1.4× the world's share of Life Sciences.

Life Sciences: 3 fractional works · 36.9% of its workNeuroscience: 2 fractional works · 27.9% of its workCellular and Molecular Neuroscience: 1 fractional works · 7.9% of its workEndocrine and Autonomic Systems: 0 fractional works · 6.2% of its workBehavioral Neuroscience: 0 fractional works · 4.7% of its workCognitive Neuroscience: 0 fractional works · 4.7% of its workDevelopmental Neuroscience: 0 fractional works · 4.4% of its workBiochemistry, Genetics and Molecular Biology: 0 fractional works · 5.7% of its workMolecular Biology: 0 fractional works · 5.7% of its workImmunology and Microbiology: 0 fractional works · 3.3% of its workImmunology: 0 fractional works · 3.3% of its workHealth Sciences: 3 fractional works · 36.1% of its workMedicine: 2 fractional works · 31.6% of its workSurgery: 1 fractional works · 9.6% of its workEpidemiology: 0 fractional works · 4.9% of its workNeurology: 0 fractional works · 4.9% of its workPulmonary and Respiratory Medicine: 0 fractional works · 2.7% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 2.4% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 1.6% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 1.1% of its workEmergency Medicine: 0 fractional works · 1.1% of its workPsychiatry and Mental health: 0 fractional works · 1.0% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 1.0% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.6% of its workPhysiology: 0 fractional works · 0.6% of its workHealth Professions: 0 fractional works · 4.4% of its workPharmacy: 0 fractional works · 4.0% of its workGeneral Health Professions: 0 fractional works · 0.4% of its workSocial Sciences: 2 fractional works · 26.0% of its workPsychology: 2 fractional works · 26.0% of its workSocial Psychology: 2 fractional works · 24.3% of its workDevelopmental and Educational Psychology: 0 fractional works · 1.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysical Sciences: 0 fractional works · 1.0% of its workChemistry: 0 fractional works · 1.0% of its workOrganic Chemistry: 0 fractional works · 1.0% of its workALL ITS WORKAzevanPharmaceuticals…7fractional works, all years
Life Sciences37%Physical Sciences1%Health Sciences36%Social Sciences26%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 7 fields, with their numbers
    1. Neuroscience227.9%
    2. Biochemistry, Genetics and Molecular Biology05.7%
    3. Immunology and Microbiology03.3%
    1. Medicine231.6%
    2. Health Professions04.4%
    1. Psychology226.0%
    1. Chemistry01.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from Azevan Pharmaceuticals (United States)?

The most cited paper from Azevan Pharmaceuticals (United States) is "Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent" (Syed Faizan Mehdi, Suma Pusapati, Muhammad Saad Anwar et al., 2023), with 303 citations. Next come "Orally active vasopressin V1a receptor antagonist, SRX251, selectively blocks aggressive behavior" (105) and "Azetidinones as vasopressin V1a antagonists" (75).

Most cited papers
#PaperReleasedCitations
1 Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent Syed Faizan Mehdi, Suma Pusapati, Muhammad Saad Anwar et al. · Frontiers in Immunology Open access 17 May 2023 303
2 Orally active vasopressin V1a receptor antagonist, SRX251, selectively blocks aggressive behavior Craig F. Ferris, Shi‐fang Lu, Tara L. Messenger et al. · Pharmacology Biochemistry and Behavior Feb 2006 105
3 Azetidinones as vasopressin V1a antagonists Christophe D. Guillon, GARY A. KOPPEL, Michael Brownstein et al. · Bioorganic & Medicinal Chemistry Open access 26 Dec 2006 75
4 Neuroradiological Changes Following Single or Repetitive Mild TBI Praveen P. Kulkarni, Thomas R. Morrison, Xuezhu Cai et al. · Frontiers in Systems Neuroscience Open access 2 Aug 2019 63
5 A novel V1a receptor antagonist blocks vasopressin-induced changes in the CNS response to emotional stimuli: an fMRI study Royce J. Lee, Emil F. Coccaro, Henk R. Cremers et al. · Frontiers in Systems Neuroscience Open access 2013 51
All 20 most cited papers, with filters and sorting

Which research topics does Azevan Pharmaceuticals (United States) publish most on?

By volume in 2022-now: Neuroendocrine regulation and behavior, Anesthesia and Neurotoxicity Research, Stress Responses and Cortisol and Adipokines, Inflammation, and Metabolic Diseases.

Neuroendocrine regulatio…0Neuroendocrine regulation and behavior: 0 fractional worksAnesthesia and Neurotoxicity Research: 0 fractional worksStress Responses and Cor…0Stress Responses and Cortisol: 0 fractional worksAdipokines, Inflammation…0Adipokines, Inflammation, and Metabolic Diseases: 0 fractional worksSepsis Diagnosis and Treatment: 0 fractional worksDiabetes Treatment and Management: 0 fractional worksAdrenal Hormones and Dis…0Adrenal Hormones and Disorders: 0 fractional worksElectrolyte and hormonal disorders: 0 fractional worksReproductive System and Pregnancy: 0 fractional worksIntensive Care Unit Cogn…0Intensive Care Unit Cognitive Disorders: 0 fractional works
Social PsychologyDevelopmental NeuroscienceBehavioral NeuroscienceEpidemiology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Neuroendocrine regulation and behavior Social Psychology 0 works
  2. 2 Anesthesia and Neurotoxicity Research Developmental Neuroscience 0 works
  3. 3 Stress Responses and Cortisol Behavioral Neuroscience 0 works
  4. 4 Adipokines, Inflammation, and Metabolic Diseases Epidemiology 0 works
  5. 5 Sepsis Diagnosis and Treatment Epidemiology 0 works
  6. 6 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 0 works
  7. 7 Adrenal Hormones and Disorders Endocrinology, Diabetes and Metabolism 0 works
  8. 8 Electrolyte and hormonal disorders Pulmonary and Respiratory Medicine 0 works
  9. 9 Reproductive System and Pregnancy Immunology 0 works
  10. 10 Intensive Care Unit Cognitive Disorders Critical Care and Intensive Care Medicine 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available50.2%not open49.8%

World: 40% of research is openly available.

with international co-authors5.3%domestic only94.7%

World: 18% is written across borders.

How has Azevan Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 28% lower than in 2018-2021.

still counting2010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Azevan Pharmaceuticals (United States) as a percentage of every work published that year, 0.0000062% in 2024.

still counting0.000020%0.000040%Azevan Pharmaceuticals (United States)0.0000043% in 202520102020

Fractional works of Azevan Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Bethlehem

All research institutions in Bethlehem

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Azevan Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.